Interventional Cardiology

SANTA CLARA, Calif., June 17, 2026 VahatiCor, Inc., a medical device company focused on developing innovative therapies for coronary...

WHIPPANY, N.J., May 21, 2026 Bayer has announced that the U.S. Food and Drug Administration (FDA) has granted Priority...

SAN CLEMENTE, Calif., May 20, 2026 Reflow Medical, Inc. has announced encouraging six-month clinical results from its DEEPER CORONARY...

AMSTERDAM, Netherlands, May 18, 2026 Royal Philips has introduced SmartIQ, a breakthrough AI-enabled coronary imaging technology developed for its...

FLAGSTAFF, Ariz., May 11, 2026 Corvention announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...

GALWAY, Ireland, May 10, 2026 WhiteSwell announced positive primary clinical results from the DELTA-HF feasibility trial evaluating its investigational...

ABBOTT PARK, Illinois, USA, April 28, 2026 Abbott has announced that its next-generation Ultreon™ 3.0 AI-powered coronary imaging platform...

Amsterdam, Netherlands – April 23, 2026 Philips announced the launch of its next-generation Bridge Plus Occlusion Balloon, a life-saving...

BALTIMORE, MARYLAND, USA, April 13, 2026 Protaryx Medical has received U.S. FDA 510(k) clearance for its Transseptal Puncture Device,...

Philadelphia, Pennsylvania, USA, April 6, 2026 Optimized Phase 2 Design Targets Faster Clinical Development In a strategic move to...